Change Over Time In The Profile Of Ankylosing Spondylitis Patients Treated With Infliximab In Canadian Routine Care

被引：0
|
作者：
Choquette, Denis [1 ]
Starr, Michael [2 ]
Khraishi, Majed M. [3 ]
Bensen, William G. [4 ,5 ]
Shaikh, Saeed A. [6 ]
Rodrigues, Jude F.
Sholter, Dalton E. [7 ]
Sheriff, Maqbool K. [8 ]
Vaillancourt, Julie [9 ]
Sampalis, John S. [10 ]
Lehman, Allen J. [11 ]
Otawa, Susan M. [11 ]
Nantel, Francois [11 ]
Shawi, May [11 ]
机构：
[1] Inst Rhumatol Montreal, Montreal, PQ, Canada
[2] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[3] Mem Univ Newfoundland, Nexus Clin Res, MD, St John, NF, Canada
[4] St Josephs Hosp, Hamilton, ON, Canada
[5] McMaster Univ, Hamilton, ON, Canada
[6] McMaster Univ, St Catharines, ON, Canada
[7] Rheumatol Associates, Edmonton, AB, Canada
[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada
[9] JSS Med Res, Montreal, PQ, Canada
[10] JSS Med Res, St Laurent, PQ, Canada
[11] Janssen Canada Inc, Toronto, ON, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2458
引用
收藏
页码：S1051 / S1051
页数：1
相关论文
共 50 条
  • [31] GENDER SPECIFIC DIFFERENCES IN ANKYLOSING SPONDYLITIS AT TREATMENT INITIATION IN PATIENTS TREATED WITH INFLIXIMAB OR GOLIMUMAB
    Starr, M.
    Zummer, M.
    Choquette, D.
    Haraoui, B.
    Rahman, P.
    Sheriff, M.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Lehman, A. J.
    Maslova, K.
    Nantel, F.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1138 - 1139
  • [32] Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab
    Starr, Michael
    Zummer, Michel
    Choquette, Denis
    Haraoui, Boulos
    Rahman, Proton
    Sheriff, Maqbool
    Jones, Niall
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Osborne, Brendan
    Lehman, Allen J.
    Maslova, Karina
    Nantel, Francois
    Tkaczyk, Cathy
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care
    Bessette, Louis
    Khraishi, Majed
    Stewart, Jacqueline
    Chow, Andrew
    Pavlova, Viktoria
    Florica, Brandusa
    Remple, Valencia P.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [34] Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care
    Bessette, Louis
    Khraishi, Majed
    Stewart, Jaqueline
    Chow, Andrew
    Pavlova, Viktoria
    Florica, Brandusa
    Remple, Valencia
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 850 - 851
  • [35] Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period
    Braun, Juergen
    Doedhar, Atul
    Dijkmans, Ben
    Geusens, Piet
    Sieper, Joachim
    Williamson, Paul
    Xu, Weichun
    Visvanathan, Sudha
    Baker, Daniel
    Goldstein, Neil
    Van Der Heijde, Desiree
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (09): : 1270 - 1278
  • [36] Lipids profile in patients with ankylosing spondylitis
    Stanek, A.
    Cieslar, G.
    Wielkozynski, T.
    Sieron, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 8 - 8
  • [37] Are Patients with Ankylosing Spondylitis Willing to Pay for Treatment with Infliximab?
    Webers, Casper
    Essers, Ivette
    van Tubergen, Astrid
    Braun, Juergen
    Heldmann, Frank
    Baraliakos, Xenofon
    Boonen, Annelies
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] The effect of infliximab on depressive symptoms in patients with ankylosing spondylitis
    Ersozlu-Bozkirli, E. D.
    Keskek, S. O.
    Bozkirli, E.
    Yucel, A. E.
    ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (03): : 262 - 267
  • [39] Infliximab (remicade TM) in the management of ankylosing spondylitis patients
    Ferreira, J
    Canhao, H
    Pimentel, F
    Mediavilla, M
    Castelao, W
    da Silva, JC
    Patto, JV
    de Queiroz, MV
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 248 - 248
  • [40] Efficacy of infliximab in subgroups of patients with ankylosing spondylitis: Results from the ankylosing spondylitis study for the evaluation of recombinant infliximab therapy (ASSERT)
    Braun, J
    Maksymowych, WP
    Dougados, M
    Steinfeld, S
    Dewoody, K
    Williamson, P
    Van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
12345